Patience and persistence on the part of AbbVie (NYSE: ABBV ) may be close to paying off in its pursuit of Shire plc (NASDAQ: SHPG )
. Shire's management has indicated that it can recommend AbbVie's
latest offer, and it is an offer that still leaves some upside for
AbbVie and its shareholders. It's definitely not a done deal though –
not only might the two companies come to an impasse over "other items"
still to be resolved, but now that the price is more or less set other
bidders may jump into the fray.
Follow this link to the full article:
AbbVie and Shire Close, but Not There Yet
No comments:
Post a Comment